619 related articles for article (PubMed ID: 32941438)
1. Anti-biofilm activity of chlorhexidine digluconate against Candida albicans vaginal isolates.
Alvendal C; Mohanty S; Bohm-Starke N; Brauner A
PLoS One; 2020; 15(9):e0238428. PubMed ID: 32941438
[TBL] [Abstract][Full Text] [Related]
2. Quercetin Assists Fluconazole to Inhibit Biofilm Formations of Fluconazole-Resistant Candida Albicans in In Vitro and In Vivo Antifungal Managements of Vulvovaginal Candidiasis.
Gao M; Wang H; Zhu L
Cell Physiol Biochem; 2016; 40(3-4):727-742. PubMed ID: 27915337
[TBL] [Abstract][Full Text] [Related]
3. Biofilms Formed by Isolates from Recurrent Vulvovaginal Candidiasis Patients Are Heterogeneous and Insensitive to Fluconazole.
Sherry L; Kean R; McKloud E; O'Donnell LE; Metcalfe R; Jones BL; Ramage G
Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28696240
[TBL] [Abstract][Full Text] [Related]
4. Antifungal activity of cathelicidin peptides against planktonic and biofilm cultures of Candida species isolated from vaginal infections.
Scarsini M; Tomasinsig L; Arzese A; D'Este F; Oro D; Skerlavaj B
Peptides; 2015 Sep; 71():211-21. PubMed ID: 26238597
[TBL] [Abstract][Full Text] [Related]
5. Proanthocyanidin polymeric tannins from Stryphnodendron adstringens are effective against Candida spp. isolates and for vaginal candidiasis treatment.
de Freitas ALD; Kaplum V; Rossi DCP; da Silva LBR; Melhem MSC; Taborda CP; de Mello JCP; Nakamura CV; Ishida K
J Ethnopharmacol; 2018 Apr; 216():184-190. PubMed ID: 29325916
[TBL] [Abstract][Full Text] [Related]
6. Candida albicans survival, growth and biofilm formation are differently affected by mouthwashes: an in vitro study.
Paulone S; Malavasi G; Ardizzoni A; Orsi CF; Peppoloni S; Neglia RG; Blasi E
New Microbiol; 2017 Jan; 40(1):45-52. PubMed ID: 28217816
[TBL] [Abstract][Full Text] [Related]
7. [In vitro biofilm formation and relationship with antifungal resistance of Candida spp. isolated from vaginal and intrauterine device string samples of women with vaginal complaints].
Calışkan S; Keçeli Özcan S; Cınar S; Corakçı A; Calışkan E
Mikrobiyol Bul; 2011 Oct; 45(4):697-706. PubMed ID: 22090300
[TBL] [Abstract][Full Text] [Related]
8. Cyclosporine A decreases the fluconazole minimum inhibitory concentration of Candida albicans clinical isolates but not biofilm formation and cell growth.
Wibawa T; Nurrokhman ; Baly I; Daeli PR; Kartasasmita G; Wijayanti N
Trop Biomed; 2015 Mar; 32(1):176-82. PubMed ID: 25801268
[TBL] [Abstract][Full Text] [Related]
9. The in vitro and in vivo efficacy of fluconazole in combination with farnesol against Candida albicans isolates using a murine vulvovaginitis model.
Bozó A; Domán M; Majoros L; Kardos G; Varga I; Kovács R
J Microbiol; 2016 Nov; 54(11):753-760. PubMed ID: 27796932
[TBL] [Abstract][Full Text] [Related]
10. Differential Response of
Salama OE; Gerstein AC
Antimicrob Agents Chemother; 2022 May; 66(5):e0240621. PubMed ID: 35446135
[TBL] [Abstract][Full Text] [Related]
11. Susceptibility of Candida albicans biofilms grown in a constant depth film fermentor to chlorhexidine, fluconazole and miconazole: a longitudinal study.
Lamfon H; Porter SR; McCullough M; Pratten J
J Antimicrob Chemother; 2004 Feb; 53(2):383-5. PubMed ID: 14729749
[TBL] [Abstract][Full Text] [Related]
12. Vulvovaginal candidiasis: species distribution of Candida and their antifungal susceptibility pattern.
Bitew A; Abebaw Y
BMC Womens Health; 2018 Jun; 18(1):94. PubMed ID: 29902998
[TBL] [Abstract][Full Text] [Related]
13. Proanthocyanidins polymeric tannin from Stryphnodendron adstringens are active against Candida albicans biofilms.
Luiz RL; Vila TV; de Mello JC; Nakamura CV; Rozental S; Ishida K
BMC Complement Altern Med; 2015 Mar; 15():68. PubMed ID: 25886244
[TBL] [Abstract][Full Text] [Related]
14. Antifungal susceptibilities, in vitro production of virulence factors and activities of ceragenins against Candida spp. isolated from vulvovaginal candidiasis.
Hacioglu M; Guzel CB; Savage PB; Tan ASB
Med Mycol; 2019 Apr; 57(3):291-299. PubMed ID: 29846682
[TBL] [Abstract][Full Text] [Related]
15. Designed Antimicrobial Peptides for Recurrent Vulvovaginal Candidiasis Treatment.
Woodburn KW; Clemens LE; Jaynes J; Joubert LM; Botha A; Nazik H; Stevens DA
Antimicrob Agents Chemother; 2019 Nov; 63(11):. PubMed ID: 31451496
[TBL] [Abstract][Full Text] [Related]
16. Role of antifungal drug resistance in the pathogenesis of recurrent vulvovaginal candidiasis.
Lynch ME; Sobel JD; Fidel PL
J Med Vet Mycol; 1996; 34(5):337-9. PubMed ID: 8912167
[TBL] [Abstract][Full Text] [Related]
17. Chlorhexidine-impregnated PEM/THFM polymer exhibits superior activity to fluconazole-impregnated polymer against Candida albicans biofilm formation.
Salim N; Silikas N; Satterthwaite JD; Moore C; Ramage G; Rautemaa R
Int J Antimicrob Agents; 2013 Feb; 41(2):193-6. PubMed ID: 23127479
[TBL] [Abstract][Full Text] [Related]
18. The evolution of Candida species and fluconazole susceptibility among oral and vaginal isolates recovered from human immunodeficiency virus (HIV)-seropositive and at-risk HIV-seronegative women.
Sobel JD; Ohmit SE; Schuman P; Klein RS; Mayer K; Duerr A; Vazquez JA; Rampalo A;
J Infect Dis; 2001 Jan; 183(2):286-93. PubMed ID: 11204125
[TBL] [Abstract][Full Text] [Related]
19. The calcineruin inhibitor cyclosporine a synergistically enhances the susceptibility of Candida albicans biofilms to fluconazole by multiple mechanisms.
Jia W; Zhang H; Li C; Li G; Liu X; Wei J
BMC Microbiol; 2016 Jun; 16(1):113. PubMed ID: 27316338
[TBL] [Abstract][Full Text] [Related]
20. Analysis of Biofilm-Related Genes and Antifungal Susceptibility Pattern of Vaginal
Mohammadi F; Hemmat N; Bajalan Z; Javadi A
Biomed Res Int; 2021; 2021():5598907. PubMed ID: 34136569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]